Role of homoeopathic medicine Pulsatilla nigricans in management of PCOS

A STUDY ON EFFECTIVENESS OF HOMOEOPATHIC MEDICINE PULSATILLA NIGRICANS IN MANAGEMENT OF PCOS

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/060282

Enrollment

100

Registered

2023-11-28

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: PULSATILLA NIGRICANS: IN DECIMAL,CENTISIMMAL,MILLESIMMAL SCALE/1Dose - MORNING IN EMPTY STOMACH - Orally - according to patients health profile Intervention2: PULSATILLA NIGRICANS: PULS

Eligibility

Inclusion criteria

Inclusion criteria: 1.Presence of 12 or more follicles in each ovary measuring 2–9 mm in diameter 2.Increased ovarian volume ( >10 ml) 3.Ovulatory function (i.e. chronic oligo ?/amenorrhea versus regular cycles) 4.chronic anovulation 5.clinical hyperandrogenism

Exclusion criteria

Exclusion criteria: PCOS with Other Systemic illness such as,Cardiovascular diseases,Diabetes mellitus,Thyroid disorders,Metabolic syndrome, Malignant disease,congenital adrenal hyperplasia, Cushing’s syndrome and androgen ?secreting tumours

Design outcomes

Primary

Measure	Time frame
Size and Number of cysts in Ovary - changes will be primary outcomeTimepoint: 12 weeks and 24 weeks	—

Secondary

Measure	Time frame
Ovarian volume,changes in size & number of cyst in ovaryTimepoint: 24 Weeks	—

Countries

India

Contacts

Public ContactS ELAVARASAN

VINAYAKA MISSION RESEARCH FOUNDATION( DEEMED UNIVERSITY)

drklbabu@gmail.com9388370428

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026